Inventor · disambiguated record
Lenka Van Sint Fiet
Also filed as: VAN SINT FIET LENKA
8 granted patents·10 pending applications·42 citations·filing 2017–2024
84Inventor score
Top patents by PatentIndex Score
18 records- 0193US11851656B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2021·Granted Dec 26, 2023·6 cites·40 claims
- 0293US10941402B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2017·Granted Mar 9, 2021·16 cites·22 claims
- 0391US12203072B2Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2023·Granted Jan 21, 2025·1 cites·29 claims
- 0491US12018257B2Single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2023·Granted Jun 25, 2024·2 cites·13 claims
- 0590US11649454B2Single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2021·Granted May 16, 2023·4 cites·41 claims
- 0688US10988763B2Single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2017·Granted Apr 27, 2021·13 cites·20 claims
- 0785US2025223593A1Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2024·Application pending·0 cites
- 0868US2024229030A9Nucleic acid molecules for pseudouridylationUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 0964US2025154504A1Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemiaPROQR THERAPEUTICS II BV·Filed 2023·Application pending·0 cites
- 1062US11866702B2Nucleic acid molecules for pseudouridylationUNIV ROCHESTER·Filed 2019·Granted Jan 9, 2024·0 cites·24 claims
- 1157US2023323346A1Antisense oligonucleotides for rna editingPROQR THERAPEUTICS II BV·Filed 2021·Application pending·0 cites
- 1252US12398393B2RNA-editing oligonucleotides for the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2020·Granted Aug 26, 2025·0 cites·15 claims
- 1352US2023235322A1Rna editing inhibitors and methods of usePROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 1451US2022307023A1Antisense rna editing oligonucleotides comprising cytidine analogsPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 1551US2022127609A1Antisense oligonucleotides for nucleic acid editingPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 1651US2022340900A1Chemically modified oligonucleotides for rna editingPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 1750US2023039928A1Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt diseasePROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 1846US2021079393A1Antisense oligonucleotides for rna editingPROQR THERAPEUTICS II BV·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lenka Van Sint Fiet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →